Aziyo Biologics Inc. (AZYO)
NASDAQ: AZYO
· Real-Time Price · USD
1.49
0.03 (2.05%)
At close: Sep 06, 2023, 9:59 PM
Aziyo Biologics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 6.26M | 6.03M | -5.1M | 5.92M | 6.29M | 6.13M | 10.3M | 13.05M | 12.66M | 12.39M | 12.64M | 11.49M | 10.86M | 11.48M | 12.16M | 12.88M |
Cost of Revenue | 3.21M | 3.57M | 5.65M | 3.18M | 3.49M | 3.29M | 9.32M | 6.72M | 7.67M | 7.34M | 7.74M | 7.21M | 7.47M | 7.8M | 6.55M | 6.55M |
Gross Profit | 3.06M | 2.46M | 555K | 2.74M | 2.8M | 2.84M | 980K | 6.33M | 4.99M | 5.05M | 4.9M | 4.28M | 3.39M | 3.69M | 5.61M | 6.33M |
Operating Income | -9.88M | -7.92M | -14.69M | -10.23M | -8.51M | -7.37M | -9.09M | -4.51M | -5.55M | -6.32M | -8.18M | -6.92M | -7.76M | -6.98M | -4.59M | -3.7M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -9.6M | -3.92M | -27.04M | 1.29M | -28.37M | -8.51M | -10.61M | -7.96M | -5.44M | -9.9M | -9.39M | -8.14M | -9.05M | -8.3M | -2.37M | -5.05M |
Net Income | -9.61M | -3.93M | -25.61M | 1.07M | -28.18M | -9.75M | -10.62M | -7.97M | -5.44M | -9.91M | -9.4M | -8.15M | -9.06M | -8.32M | -2.38M | -5.07M |
Selling & General & Admin | 7.47M | 6.9M | 8.99M | 7.51M | 8.02M | 5.56M | 7.62M | 9.04M | 8.46M | 9.4M | 10.46M | 8.93M | 7.78M | 8.38M | 8.33M | 8.31M |
Research & Development | 1.46M | 905K | 254K | 778K | 1M | 557K | 1.17M | 1.8M | 2.08M | 1.97M | 2.62M | 2.27M | 3.38M | 2.29M | 1.88M | 1.72M |
Other Expenses | 799K | n/a | n/a | 1.5M | n/a | 810K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 9.73M | 7.81M | 9.24M | 9.79M | 9.02M | 6.93M | 8.79M | 10.84M | 10.54M | 11.37M | 13.08M | 11.2M | 11.15M | 10.66M | 10.21M | 10.03M |
Interest Expense | 518K | 1.08M | 263K | 1.13M | 1.27M | 1.45M | 1.52M | 1.54M | 1.56M | 1.3M | 1.2M | 1.22M | 1.29M | 1.33M | 1.35M | 1.35M |
Selling & Marketing Expenses | 3.78M | 3.03M | 770K | 2.99M | 3.33M | 2.8M | 3.62M | 5.36M | 5.06M | 4.92M | 5.41M | 4.82M | 4.54M | 4.78M | 4.8M | 4.7M |
Cost & Expenses | 12.93M | 11.38M | 14.89M | 12.97M | 12.51M | 10.21M | 18.11M | 17.56M | 18.22M | 18.71M | 20.82M | 18.42M | 18.62M | 18.46M | 16.75M | 16.58M |
Income Tax Expense | 8K | 8K | -29K | 8K | -11K | 12K | 12K | 12K | -2K | 12K | 12K | 12K | 12K | 12K | 18K | 13K |
Shares Outstanding (Basic) | 41.78M | 38.62M | 29.07M | 32.52M | 24.77M | 17.02M | 16.22M | 16.15M | 14.47M | 13.66M | 13.62M | 13.57M | 11.09M | 10.24M | 10.23M | 10.23M |
Shares Outstanding (Diluted) | 46.31M | 29.07M | 29.07M | 35.52M | 26.27M | 17.02M | 16.22M | 16.15M | 14.47M | 13.66M | 13.62M | 13.57M | 11.09M | 10.24M | 10.23M | 10.23M |
EPS (Basic) | -0.23 | -0.1 | -0.15 | 0.03 | -1.14 | -0.57 | -0.65 | -0.49 | -0.38 | -0.73 | -0.69 | -0.6 | -0.82 | -0.81 | -0.23 | -0.5 |
EPS (Diluted) | -0.26 | -0.14 | -0.15 | 0.03 | -1.07 | -0.57 | -0.65 | -0.49 | -0.38 | -0.73 | -0.69 | -0.6 | -0.82 | -0.81 | -0.23 | -0.5 |
EBITDA | -9.88M | -7.92M | -27.23M | -10.23M | -8.51M | -7.37M | -9.09M | -4.51M | -4.4M | -7.12M | -8.18M | -5.99M | -7.76M | -6.04M | -4.59M | -3.7M |
EBIT | n/a | n/a | 11.93M | n/a | n/a | -7.06M | n/a | -4.87M | -5.61M | -7.29M | n/a | -6.92M | n/a | -6.98M | -1.02M | n/a |
Depreciation & Amortization | n/a | n/a | -1.86M | n/a | n/a | -39.59K | 954K | 947K | 4.96M | -803K | 934K | 929K | 933K | 932K | 932K | 933K |